Overexpression of the ETS-Related Gene, <i>ERG</i>, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
Guido Marcucci(City of Hope), Clara D. Bloomfield(North Shore University Hospital), Michael D. Radmacher, Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maria R. Baer(University of Maryland, Baltimore), Albert de la Chapelle(Université Claude Bernard Lyon 1), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Joseph O. Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Krzysztof Mrózek(The Ohio State University), Bayard L. Powell(Atrium Health Wake Forest Baptist), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Susan P. Whitman(The Ohio State University Wexner Medical Center), Colin G. Edwards(University of Maryland, Baltimore), Danilo Perrotti(Cancer Genetics (United States)), James W. Vardiman(University of Chicago), Claudia D. Baldus(University Hospital Schleswig-Holstein)
Cited by 234
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k